Browse By Viral Diseases

This page shows data for Dengue fever disease.
Total Entries Retrieved: 6
IDVaccine NameDisease NameDisease ClassificationVirus NameNucleic Acid ContentVaccine TypeVaccine StatusManufacturerYear of ManufacturingManufacturing CountryAgeDosageAdministration RouteAdjuvantTarget StrainDescriptionApproving OrganisationCollaborating OrganisationOther CountriesTrade NamePMIDClinical Trial IDReference LinkAdditional Links
10087 CYD-TDV Dengvaxia Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Live-attenuated Approved Sanofi Pasteur 2015 France 9 - 45 years 3 doses 6 months apart Subcutaneous NA Dengue virus serotypes (1, 2, 3 and 4) 17D vaccine vector expressing genes of DENV-1, 2, 3, or 4 US FDA NA NA NA 30684747 NCT02747927 https://www.sciencedirect.com/science/article/pii/S1201971219300402 https://www.fda.gov/media/124379/download
10210 DENV-1 PIV Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Inactivated Phase 1 US Army Medical Research and Development Command 2015 USA 18 - 50 years 2 doses 28 days apart Intramuscular NA Dengue virus serotypes -1 NA NA NA NA NA NA NCT01502735 https://clinicaltrials.gov/ct2/show/NCT01502735?recrs=abde&cond=dengue+fever&phase=0123&draw=2&rank=5 NA
10211 rDEN3delta30/31-7164 Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Live-attenuated Phase 1 National Institute of Allergy and Infectious Diseases 2013 USA 18 - 50 years NA Subcutaneous NA Dengue virus serotypes -3 NA NA Johns Hopkins Bloomberg School of Public Health NA NA NA NCT00831012 https://clinicaltrials.gov/ct2/show/NCT00831012?recrs=abde&cond=dengue+fever&phase=0123&draw=2&rank=12 NA
10295 DSV4 Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Subunit vaccine Phase 2 Panacea Biotec Ltd NA India 2 - 60 years NA NA NA Chimeric protein containing vHBsAg,DS, unique tetravalent dengue antigen Produced using the methylotrophic yeast Pichia pastoris NA NA NA NA 30684747 NA https://www.sciencedirect.com/science/article/pii/S1201971219300402 NA
10364 TAK-003 Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Live-attenuated Phase 3 Takeda Pharmaceutical Company Limited NA USA 4 - 16 years NA Subcutaneous NA Dengue virus serotypes (1, 2, 3 and 4) Mammalian cell vero culture NA NA NA TDV 30684747 NA https://www.sciencedirect.com/science/article/pii/S1201971219300402 NA
10365 TV-003/005 Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Live-attenuated Phase 3 Merck & Co. Inc. NA Brazil 2 - 59 years NA Subcutaneous NA Dengue virus serotypes (1, 2, 3 and 4) Mammalian cell vero culture NA National Institute of Allergy and Infectious Diseases NA TetraVax-DV 30684747 NCT02406729 https://www.sciencedirect.com/science/article/pii/S1201971219300402 https://clinicaltrials.gov/ct2/show/NCT02406729